REGENERON PHARMACEUTICALS INC. - COMMON STOCK

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

20 Aug 2024 08:47:18 By NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

19 Aug 2024 08:50:04 By NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

16 Aug 2024 10:58:01 By NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

15 Aug 2024 08:45:08 By NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

14 Aug 2024 09:27:20 By NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

13 Aug 2024 08:50:04 By NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

09 Aug 2024 08:48:01 By NetDania Notify

Regeneron Announces Investor Conference Presentations and Oncology Investor Webcast

07 Aug 2024 15:05:01 By Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

02 Aug 2024 08:46:30 By NetDania Notify

Regeneron Reports Second Quarter 2024 Financial and Operating Results

01 Aug 2024 05:30:00 By Nasdaq GlobeNewswire

Regeneron Announces the 2024 Winners of the Regeneron Prize for Creative Innovation

31 Jul 2024 06:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

12 Jul 2024 08:45:06 By NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

11 Jul 2024 09:10:53 By NetDania Notify

Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD

03 Jul 2024 00:00:00 By Nasdaq GlobeNewswire

Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

28 Jun 2024 06:00:00 By Nasdaq GlobeNewswire

Regeneron to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

27 Jun 2024 15:05:00 By Nasdaq GlobeNewswire

Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine

26 Jun 2024 16:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

25 Jun 2024 08:45:03 By NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

24 Jun 2024 08:56:19 By NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

21 Jun 2024 09:29:52 By NetDania Notify